Latest News

May 16, 2025

In March 2025 it was announced that Osteoporosis Canada was one of three new charities to join the membership of HealthPartners in the mission to create a healthier Canada and support people in Canada living with serious health conditions.

HealthPartners brings workplaces, health charities and the communities they support together in a single, shared purpose — to improve the lives of people across Canada who are living with serious illness through innovative workplace fundraising campaigns.

As a member, Osteoporosis Canada together with HealthPartners provides the opportunity to reach even more workplaces, raise more funds and support an even greater number of people affected by serious health conditions.

“With nearly 90% of people in Canada likely to be affected by one of the conditions we fundraise for, the need for our collective efforts has never been greater,” said Kimberley Hanson, CEO of HealthPartners. “By joining forces with these charities, we’re broadening our reach and impact, empowering workplaces, and driving more donations for health charities who provide crucial services, education and medical research.”

“Our work to reduce the burden of osteoporosis takes on new strength with HealthPartners. Together, we’re empowering individuals and workplaces to prioritize bone health and prevent fractures before they happen.” – Dr. Famida Jiwa, President and CEO, Osteoporosis Canada.

With the expansion of new charitable partners including Osteoporosis Canada, a single donation to HealthPartners will have an even greater impact, supporting a broader range of causes. Donors can contribute to the collective fund or choose to direct their support to specific charities within our network, giving them more flexibility in how they make a difference.

For more information, please visit: www.healthpartners.ca Grows to 20 Charities, Boosting Support for Millions Across Canada

Latest News

March 19, 2025

The University of Waterloo, Kinesiology and Health Sciences Professor Lora Giangregorio has been awarded a Tier 1 Canada Research Chair (CRC) in Bone Health and Exercise Science, with a funding allotment of $1.4 million.

The Tier 1 Canada Research Chair will advance bone health and exercise science research.

Dr. Giangregorio also received a $75,000 grant from the Canada Foundation for Innovation John R. Evans Leaders Fund (JELF) that is associated with this CRC.

Dr. Giangregorio is a member of Osteoporosis Canada’s Scientific Advisory Council (SAC). Her research team has also worked with the organization to develop Bone Fit™, a two-day workshop for physiotherapists and kinesiologists on exercise prescription for those with osteoporosis.

Dr. Giangregorio is recognized for her outstanding research in reducing the burdens of osteoporotic (bone tissue) fractures. She leads the University of Waterloo Bone Health and Exercise Science Lab (BonES), working on exercise research to reduce fracture risk.

Congratulations to Dr. Giangregorio!

Click here to visit the University of Waterloo and read the full announcement.

Latest News

Angela Cheung, M.D., Ph.D. is the recipient of the 2024 Gideon A. Rodan Excellence in Mentorship Award which is given annually in recognition of outstanding support provided by a senior scientist who has helped promote the independent careers of young investigators in bone and mineral metabolism.

The ASBMR Esteemed Awards are the Society’s most prestigious awards given to members who have made significant contributions and who promote excellence in bone and mineral research.

Dr. Angela M. Cheung is Professor of Medicine at University of Toronto, Senior Physician Scientist at University Health Network, and holds a Tier 1 Canada Research Chair in Postmenopausal and Musculoskeletal Health. She obtained her M.D. from Johns Hopkins University in 1988 and her Ph.D. in Health Policy from Harvard University in 1997. She is a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for more than 30 years. Dr. Cheung is also a member of Osteoporosis Canada’s Scientific Advisory Council, a member of the IOF Council of Scientific Advisors and the President-Elect of ISCD.

This award will be presented during the ASBMR 2024 Annual Meeting in Toronto this September.

Congratulations to Dr. Angela Cheung!

Latest News

May 31, 2024

Health Canada has provided authorization to market Jubbonti^® (denosumab subcutaneous injection, reference medicine: Prolia).

Jubbonti^® is the first and only Health Canada-approved denosumab biosimilar for osteoporosis and increasing bone mass. This human monoclonal antibody and RANK ligand inhibitor (bone metabolism regulator) is approved to treat all five indications covered by the reference medicine and is available as a 60 mg/mL solution in single-use prefilled syringe. Jubbonti^® should be available on the Canadian market in the coming months.

“This announcement means that Canadians will have greater access to an important biologic therapy in the treatment of osteoporosis,” says Dr. Famida Jiwa, President and CEO, Osteoporosis Canada. “Health Canada’s approval of the denosumab biosimilar Jubbonti^®will expand and increase access to patients who are living with osteoporosis.”

Click here to visit Sandoz and read the full release.

Latest News

April  19, 2024

The International Society for Clinical Densitometry (ISCD) is the leading membership organization for professionals working to assess, monitor and treat skeletal health.

Dr. Angela Man-Wei Cheung, from University Health Network, the University of Toronto and member of Osteoporosis Canada’s Scientific Advisory Council (SAC), has recently been named the ISCD President-Elect.

Dr. Cheung served as Vice President in 2023-2024. 

ISCD is committed to improving the quality of diagnosis, treatment and care provided to patients by promoting excellence in the field of bone densitometry. ISCD provides continuing education and certification to physicians and technologists in the medical community that have an interest in the field of bone densitometry. 

ISCD is impacting quality densitometry and osteoporosis treatment in over 25 countries, from Australia to Uruguay — connecting researchers, technologists, physicians, and others with an interest in the field as well as partnering with other organizations to deliver the most impactful information to its members.

The ISCD Board of Director members are leaders in the field of densitometry and osteoporosis—top practitioners, technologists and researchers who serve to help grow and lead the industry. 

Congratulations Dr. Cheung!

Latest News

November 7, 2023

Congratulations to Dr. Alexandra Papaioannou, member of the Osteoporosis Canada Scientific Advisory Council (SAC) is one of the recipients of The 2023 CIHR Institute of Aging Betty Havens Prize for Knowledge Mobilization in Aging.

The CIHR Institute of Aging Betty Havens Prize for Knowledge Mobilization in Aging honors Betty Havens, a leading gerontologist who was committed to improving the lives of seniors with notable achievements in health services research on the aging process. This prize, based on nominations of applicants by peers, teams or organizations, recognizes an individual, team or organization that has advanced the mobilization of research in aging at a local or regional level.

Dr. Alexandra Papaioannou is a Professor of Medicine (Division of Geriatrics) at McMaster University, a Geriatric Medicine Specialist at Hamilton Health Sciences and Executive Director of the Geras Centre for Aging Research. She holds a Tier 1 Canada Research Chair in Geriatric Medicine and Healthy Aging. She is the lead clinician-scientist of the Canadian Geriatrics Society Frailty working group and a member of the Global Frailty Network.

Dr. Papaioannou is the Chair of the Regional Geriatric Program Central and past Director of the Division of Geriatric Medicine at McMaster University. She has 396+ peer-reviewed publications, 19 book chapters and 417+ published abstracts (h-index 76; 24,629+ citations). She has mentored 125+ research trainees from undergraduate to post-doctoral fellows, many of whom have received nationally-funded awards. Her program of research is focused on bringing the best research evidence to the frontlines of care for older adults to age with dignity and independence.

Congratulations to Dr. Papaioannou.